Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple bacterial proteins and cellular macromolecules" refers to a broad and non-specific set of targets within a bacterial cell, including enzymes, structural proteins, cell wall components, and nucleic acids. This aggregate target is characteristic of biocides, antiseptics, and certain heavy metal-based antimicrobials rather than highly selective systemic antibiotics (Source: CDC Guideline for Disinfection and Sterilization). For instance, silver ions exert their antimicrobial effect by binding to bacterial DNA, disrupting the cell wall, and inactivating essential metabolic enzymes simultaneously (Source: PMC6264685). Similarly, oxidizing agents like povidone-iodine cause widespread damage to proteins and fatty acids, leading to rapid microbial death (Source: StatPearls, NBK559071). Because these agents attack numerous essential components at once, the development of bacterial resistance via single-point mutations is significantly hindered. However, this lack of specificity often results in a narrow therapeutic index, as the same mechanisms can damage human host tissues. Consequently, drugs interacting with these multiple targets are primarily restricted to topical applications, wound care, and environmental disinfection (Source: PubChem, CID 65537).
Antimicrobial agents targeting multiple bacterial macromolecules typically act through non-specific mechanisms such as oxidative stress, protein denaturation, covalent cross-linking of nucleic acids, and disruption of the lipid bilayer (Source: StatPearls, NBK559071; PMC6264685).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple bacterial proteins and cellular macromolecules.